部分miRNA在糖尿病性心肌病病理生理过程中的作用(4)
[7] Chen S,Puthanveetil P,Feng B,et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med,2014,18(3):415-421.
[8] Falcao-Pires I,Leite-Moreira A F.Diabetic cardiomyopathy:understanding the molecular and cellular basis to progress in diagnosis and treatment[J].Heart Fail Rev,2012,17(3):325-344.
[9] Gulati A,Jabbour A,Ismail T F,et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA,2013,309(9):896-908.
, http://www.100md.com
[10] Cheng Y,Zhang D,Zhu M,et al.Liver X receptor alpha is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through ROS-mediated mitochondrial pathway[J].Biochem Cell Biol,2018,96(1):11-18.
[11] Dludla P V,Nkambule B B,Dias S C,et al.Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage:a protocol for a systematic review[J].Syst Rev,2017,6(1):96.
[12] Li D,Liu M,Tao T Q,et al.Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion[J].Cell Physiol Biochem,2014,34(4):1413-1426.
, 百拇医药
[13] Zhai C,Tang G,Peng L,et al.Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta[J].Am J Transl Res,2015,7(10):1952-1962.
[14] Feng B,Chakrabarti S.miR-320 Regulates Glucose-Induced Gene Expression in Diabetes[J].ISRN Endocrinol,2012,2012:549875.
[15] Chen S,Puthanveetil P,Feng B,et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med,2014,18(3):415-421.
, http://www.100md.com
[16] de Gonzalo-Calvo D,van der Meer R W,Rijzewijk L J,et al.
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes[J].Sci Rep,2017,7(1):47.
[17] Li Y,Yang C M,Xi Y,et al.MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia[J].Int J Cardiol,2013,167(3):1076-1078.
, 百拇医药 [18] de Gonzalo-Calvo D,Iglesias-Gutierrez E,Llorente-Cortes V.
Epigenetic Biomarkers and Cardiovascular Disease:Circulating MicroRNAs[J].Rev Esp Cardiol(Engl Ed),2017,70(9):763-769.
[19] Lorenzen J,Kumarswamy R,Dangwal S,et al.MicroRNAs in diabetes and diabetes-associated complications[J].RNA Biology,2014,9(6):820-827.
[20] Chavali V,Tyagi S C,Mishra P K.Predictors and prevention of diabetic cardiomyopathy[J].Diabetes Metab Syndr Obes,2013,6:151-160., http://www.100md.com(叶小林 李涛 吴柱国)
[8] Falcao-Pires I,Leite-Moreira A F.Diabetic cardiomyopathy:understanding the molecular and cellular basis to progress in diagnosis and treatment[J].Heart Fail Rev,2012,17(3):325-344.
[9] Gulati A,Jabbour A,Ismail T F,et al.Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J].JAMA,2013,309(9):896-908.
, http://www.100md.com
[10] Cheng Y,Zhang D,Zhu M,et al.Liver X receptor alpha is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through ROS-mediated mitochondrial pathway[J].Biochem Cell Biol,2018,96(1):11-18.
[11] Dludla P V,Nkambule B B,Dias S C,et al.Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage:a protocol for a systematic review[J].Syst Rev,2017,6(1):96.
[12] Li D,Liu M,Tao T Q,et al.Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion[J].Cell Physiol Biochem,2014,34(4):1413-1426.
, 百拇医药
[13] Zhai C,Tang G,Peng L,et al.Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta[J].Am J Transl Res,2015,7(10):1952-1962.
[14] Feng B,Chakrabarti S.miR-320 Regulates Glucose-Induced Gene Expression in Diabetes[J].ISRN Endocrinol,2012,2012:549875.
[15] Chen S,Puthanveetil P,Feng B,et al.Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes[J].J Cell Mol Med,2014,18(3):415-421.
, http://www.100md.com
[16] de Gonzalo-Calvo D,van der Meer R W,Rijzewijk L J,et al.
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes[J].Sci Rep,2017,7(1):47.
[17] Li Y,Yang C M,Xi Y,et al.MicroRNA-1/133 targeted dysfunction of potassium channels KCNE1 and KCNQ1 in human cardiac progenitor cells with simulated hyperglycemia[J].Int J Cardiol,2013,167(3):1076-1078.
, 百拇医药 [18] de Gonzalo-Calvo D,Iglesias-Gutierrez E,Llorente-Cortes V.
Epigenetic Biomarkers and Cardiovascular Disease:Circulating MicroRNAs[J].Rev Esp Cardiol(Engl Ed),2017,70(9):763-769.
[19] Lorenzen J,Kumarswamy R,Dangwal S,et al.MicroRNAs in diabetes and diabetes-associated complications[J].RNA Biology,2014,9(6):820-827.
[20] Chavali V,Tyagi S C,Mishra P K.Predictors and prevention of diabetic cardiomyopathy[J].Diabetes Metab Syndr Obes,2013,6:151-160., http://www.100md.com(叶小林 李涛 吴柱国)
参见:首页 > 医疗版 > 疾病专题 > 内分泌科 > 糖尿病